NextCure, Inc. (NXTC) Misses Q2 EPS by 17c
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Join SI Premium – FREE
NextCure, Inc. (NASDAQ: NXTC) reported Q2 EPS of ($0.55), $0.17 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
